291 related articles for article (PubMed ID: 28720048)
21. Lupus nephritis: is the kidney biopsy currently necessary in the management of lupus nephritis?
Giannico G; Fogo AB
Clin J Am Soc Nephrol; 2013 Jan; 8(1):138-45. PubMed ID: 22977215
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of renal biopsies showing mixed mesangial and global proliferative lupus nephritis.
Baumal R; Farine M; Poucell S
Am J Kidney Dis; 1987 Sep; 10(3):236-40. PubMed ID: 3631071
[TBL] [Abstract][Full Text] [Related]
23. Patterns of renal disease in South Korea: a 20-year review of a single-center renal biopsy database.
Shin HS; Cho DH; Kang SK; Kim HJ; Kim SY; Yang JW; Kang GH; Kim YN; Jung Y; Cheon BK; Rim H
Ren Fail; 2017 Nov; 39(1):540-546. PubMed ID: 28722531
[TBL] [Abstract][Full Text] [Related]
24. [The significance of urinary podocytes in patients with active lupus nephritis].
Li JZ; Liu Y; E J; Huang HC; Yu F; Zou WZ; Wang HY
Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):127-30. PubMed ID: 17445439
[TBL] [Abstract][Full Text] [Related]
25. Significance of histological crescent formation in patients with diffuse proliferative lupus nephritis.
Chen S; Tang Z; Zhang Y; Liu Z; Zhang H; Hu W; Liu Z
Am J Nephrol; 2013; 38(6):445-52. PubMed ID: 24247741
[TBL] [Abstract][Full Text] [Related]
26. The associations of endothelial and podocyte injury in proliferative lupus nephritis: from observational analysis to in vitro study.
Yuan M; Tan Y; Wang Y; Wang SX; Yu F; Zhao MH
Lupus; 2019 Mar; 28(3):347-358. PubMed ID: 30755145
[TBL] [Abstract][Full Text] [Related]
27. Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy.
Hill GS; Delahousse M; Nochy D; Thervet E; Vrtovsnik F; Rémy P; Glotz D; Bariéty J
Kidney Int; 2002 Jun; 61(6):2176-86. PubMed ID: 12028458
[TBL] [Abstract][Full Text] [Related]
28. Nephrotic syndrome, hematuria, and hypocomplementemia in a case of mesangial lupus nephritis evolving later to a membranous lesion.
Bakir AA; Rhee HL; Ainis H; Dunea G
Am J Med; 1989 May; 86(5):609-11. PubMed ID: 2712069
[No Abstract] [Full Text] [Related]
29. Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis.
Hill GS; Delahousse M; Nochy D; Bariéty J
Kidney Int; 2005 Nov; 68(5):2288-97. PubMed ID: 16221231
[TBL] [Abstract][Full Text] [Related]
30. Lupus Podocytopathy: A Rare Cause of Nephrotic Syndrome in Patients with Systemic Lupus Erythematosus.
Khan O; Mohammadrezaei F; Aslam S; Khan MH; Wilches RDM; Singh S; Scheers-Masters J
J Community Hosp Intern Med Perspect; 2023; 13(5):57-60. PubMed ID: 37868666
[TBL] [Abstract][Full Text] [Related]
31. [Clinical analysis of acute kidney injury in children with renal diseases].
Zhong XH; Ding J; Liu XY; Xiao HJ; Yao Y; Huang JP
Zhonghua Er Ke Za Zhi; 2011 Jan; 49(1):60-5. PubMed ID: 21429314
[TBL] [Abstract][Full Text] [Related]
32. Proteinuria in membranous lupus nephritis: the pathology is in the podocyte.
Desai N; Cimbaluk D; Lewis EJ; Whittier WL
Lupus; 2013 Apr; 22(5):461-8. PubMed ID: 23428848
[TBL] [Abstract][Full Text] [Related]
33. Twenty-eight-year review of childhood renal diseases from renal biopsy data: A single centre in China.
Jiang M; Xiao Z; Rong L; Xu Y; Chen L; Mo Y; Sun L; Sun W; Jiang X
Nephrology (Carlton); 2016 Dec; 21(12):1003-1009. PubMed ID: 26698187
[TBL] [Abstract][Full Text] [Related]
34. The clinicopathological features and renal prognostic factors in pure membranous lupus nephritis-a large series cohort study from China.
Hu J; Zhu M; Wang J; Lou W; Zhang H
Lupus; 2024 Feb; 33(2):192-200. PubMed ID: 38158842
[TBL] [Abstract][Full Text] [Related]
35. [A case report of lupus nephritis associated with minimal change nephrotic syndrome--comparison of various histological types of 67 cases with lupus nephritis].
Okai T; Soejima A; Suzuki M; Yomogida S; Nakabayashi K; Kitamoto K; Nagasawa T
Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):835-40. PubMed ID: 1479724
[TBL] [Abstract][Full Text] [Related]
36. Minimal change disease in systemic lupus erythematosus.
Dube GK; Markowitz GS; Radhakrishnan J; Appel GB; D'Agati VD
Clin Nephrol; 2002 Feb; 57(2):120-6. PubMed ID: 11863121
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for acute kidney injury and kidney relapse in patients with lupus podocytopathy.
Xia W; Deng J; Zhuang L; Xu F; Jin Y; Zhou H; Zhang T; Liu Z; Zhang H; Zeng C; Liu Z; Hu W
Clin Kidney J; 2024 Jun; 17(6):sfae148. PubMed ID: 38835511
[TBL] [Abstract][Full Text] [Related]
38. Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients.
Ma R; Jiang W; Li Z; Sun Y; Wei Z
Lupus; 2016 Dec; 25(14):1577-1586. PubMed ID: 27147620
[TBL] [Abstract][Full Text] [Related]
39. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis.
Couzi L; Merville P; Deminière C; Moreau JF; Combe C; Pellegrin JL; Viallard JF; Blanco P
Arthritis Rheum; 2007 Jul; 56(7):2362-70. PubMed ID: 17599764
[TBL] [Abstract][Full Text] [Related]
40. Plasma ADAMTS-13 activity in proliferative lupus nephritis: a large cohort study from China.
Tan Y; Luan ZQ; Hao JB; Song D; Yu F; Zhao MH
Lupus; 2018 Mar; 27(3):389-398. PubMed ID: 28786769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
